Actavis Buys Forest Labs For $25 Billion

Actavis (NYSE: ACT) will pay a premium of approximately $25 billion in cash and stock to acquire Forest Laboratories Inc. (NYSE: FRX). Shares of Forest Laboratories jumped $20.38 to $91.78 while Actavis stock leaped $12.15 to $204.03.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.